Biotech M&A in 2026: What due diligence means for scientific validity, IP, and regulatory hurdles. Avoid financial loss; ensure sound investments.
Editorial Team
·
2026 typhoons threaten 60% of global shipping. Learn why supply chains are vulnerable and how to prepare for potential $200B economic losses.
·
Climate change is rerouting global trade. Learn how droughts impact the Panama Canal and why companies are nearshoring by 2030.
·
How are biotech VCs changing strategies in 2026? Learn why clinical trials and regulatory clarity are now key for funding early-stage biopharma.
·
How do we get affordable drugs? EU and US policies, like the Inflation Reduction Act, balance innovation with drug access. See what's next.
·
·
6 min read
Fragmented cybersecurity threatens global infrastructure. Learn why 2026 UN frameworks must boost intelligence sharing, common laws & incident reporting.
·
·
7 min read
AI rules lag, leaving kids vulnerable by 2026. Learn why current laws fail on data privacy and bias, and what safeguards are needed now.
·
·
9 min read
Global AI ethics diverge in 2024. See how the EU's AI Act, US voluntary rules, and China's state control shape responsible AI development.
·
·
7 min read
Market data flows will hit 300 petabytes daily by 2026. See how AI, real-time indicators, and new regulations are reshaping finance.
·
·
6 min read
CBP is changing import rules by 2026. Learn how new transparency demands and UFLPA enforcement impact your business and what to do now.
·
·
7 min read
